| 000 | 01610 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515173505.0 | ||
| 264 | 0 | _c20110509 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-009-1035-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDas, Tanushree | |
| 245 | 0 | 0 |
_aEffect of antisense oligomer in controlling c-raf.1 overexpression during diethylnitrosamine-induced hepatocarcinogenesis in rat. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cJan 2010 |
||
| 300 |
_a309-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xchemically induced |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDiethylnitrosamine |
| 650 | 0 | 4 | _aHyperplasia |
| 650 | 0 | 4 | _aLipid Peroxidation |
| 650 | 0 | 4 |
_aLiver Neoplasms _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aPrecancerous Conditions _xchemically induced |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-raf _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aPatra, Falguni | |
| 700 | 1 | _aMukherjee, Biswajit | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 65 _gno. 2 _gp. 309-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-009-1035-4 _zAvailable from publisher's website |
| 999 |
_c18923199 _d18923199 |
||